Wuhan Keqian Biological Co., Ltd., Wuhan, China.
Wuhan Keqian Biological Co., Ltd., Wuhan, China.
Anal Biochem. 2019 May 1;572:52-57. doi: 10.1016/j.ab.2019.02.024. Epub 2019 Mar 4.
Since 2013, the H7 subtype avian influenza virus (AIV-H7) has seriously endangered human life and health, and has had a serious impact on the poultry industry in China. A competitive enzyme-linked immunosorbent assay (C-ELISA) which detects the antibody for AIV-H7 was developed, basing on a monoclonal antibody (mAb) against the neutralizing epitopes on hemagglutinin (HA)gene. Twelve hybridoma cell lines were screened by cell fusion. Hemagglutination inhibition (HI) assay and indirect ELISA were used to identify the competitive effect of the mAbs. High-affinity mAb 1H11 was selected as a competitive antibody. The reaction conditions for the C-ELISA were optimized for AIV-H7 antibody detection. The cross-reactivity of the C-ELISA was determined by AIV-(H1H15), NDV, IBV and IBDV positive serum. A total of 1294 field samples (chicken (462), duck (318), goose (219), quail (203) and pigeon (92) were simultaneously detected by C-ELISA and HI assay. The C-ELISA was found to have a high specificity of 93.23% and a sensitivity of 96.24%. These results reveal a positive coincidence between C-ELISA and HI assay at a coincidence rate of 97.52%. In addition, It confirmed that this method can be used for the diagnosis of AIV-H7 antibodies from chicken, ducks, goose, quail and pigeons.
自 2013 年以来,H7 亚型禽流感病毒(AIV-H7)严重威胁着人类的生命和健康,对中国的家禽业产生了严重影响。本研究基于针对血凝素(HA)基因中和表位的单克隆抗体(mAb),建立了检测 AIV-H7 抗体的竞争酶联免疫吸附试验(C-ELISA)。通过细胞融合筛选出 12 株杂交瘤细胞系。通过血凝抑制(HI)试验和间接 ELISA 鉴定 mAbs 的竞争效果。选择高亲和力 mAb 1H11 作为竞争抗体。优化了 C-ELISA 检测 AIV-H7 抗体的反应条件。通过 AIV-(H1H15)、新城疫病毒(NDV)、传染性支气管炎病毒(IBV)和传染性法氏囊病病毒(IBDV)阳性血清确定了 C-ELISA 的交叉反应性。同时采用 C-ELISA 和 HI 法检测了 1294 份临床样本(鸡 462 份、鸭 318 份、鹅 219 份、鹌鹑 203 份和鸽 92 份)。结果显示,C-ELISA 具有很高的特异性(93.23%)和敏感性(96.24%)。C-ELISA 与 HI 法的符合率为 97.52%。此外,该方法可用于鸡、鸭、鹅、鹌鹑和鸽 AIV-H7 抗体的诊断。